STAT3 and neoplasm: Within tumors, IL-6 is known to stimulate tumor growth, survival, angiogenesis, and evasion of immune detection via IL-6/STAT3 signaling, as well as to enhance and propagate oncogenic signals within the TME, thereby promoting tumorigenesis, invasion, and metastasis [12].